Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

1.

The many faces of REST oversee epigenetic programming of neuronal genes.

Ballas N, Mandel G.

Curr Opin Neurobiol. 2005 Oct;15(5):500-6. Review.

PMID:
16150588
2.

Transcriptional regulation: cancer, neurons and the REST.

Coulson JM.

Curr Biol. 2005 Sep 6;15(17):R665-8. Review.

3.

A genetic screen for candidate tumor suppressors identifies REST.

Westbrook TF, Martin ES, Schlabach MR, Leng Y, Liang AC, Feng B, Zhao JJ, Roberts TM, Mandel G, Hannon GJ, Depinho RA, Chin L, Elledge SJ.

Cell. 2005 Jun 17;121(6):837-48.

4.

REST and its corepressors mediate plasticity of neuronal gene chromatin throughout neurogenesis.

Ballas N, Grunseich C, Lu DD, Speh JC, Mandel G.

Cell. 2005 May 20;121(4):645-57.

5.
6.

Identification of human brain tumour initiating cells.

Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD, Dirks PB.

Nature. 2004 Nov 18;432(7015):396-401.

7.

Suppression of the Shh pathway using a small molecule inhibitor eliminates medulloblastoma in Ptc1(+/-)p53(-/-) mice.

Romer JT, Kimura H, Magdaleno S, Sasai K, Fuller C, Baines H, Connelly M, Stewart CF, Gould S, Rubin LL, Curran T.

Cancer Cell. 2004 Sep;6(3):229-40.

8.

Activation of REST/NRSF target genes in neural stem cells is sufficient to cause neuronal differentiation.

Su X, Kameoka S, Lentz S, Majumder S.

Mol Cell Biol. 2004 Sep;24(18):8018-25.

9.

Histopathological and molecular prognostic markers in medulloblastoma: c-myc, N-myc, TrkC, and anaplasia.

Eberhart CG, Kratz J, Wang Y, Summers K, Stearns D, Cohen K, Dang CV, Burger PC.

J Neuropathol Exp Neurol. 2004 May;63(5):441-9.

PMID:
15198123
10.

Conversion of myoblasts to physiologically active neuronal phenotype.

Watanabe Y, Kameoka S, Gopalakrishnan V, Aldape KD, Pan ZZ, Lang FF, Majumder S.

Genes Dev. 2004 Apr 15;18(8):889-900. Epub 2004 Apr 12.

11.

A resource for large-scale RNA-interference-based screens in mammals.

Paddison PJ, Silva JM, Conklin DS, Schlabach M, Li M, Aruleba S, Balija V, O'Shaughnessy A, Gnoj L, Scobie K, Chang K, Westbrook T, Cleary M, Sachidanandam R, McCombie WR, Elledge SJ, Hannon GJ.

Nature. 2004 Mar 25;428(6981):427-31.

PMID:
15042091
12.

A small modulatory dsRNA specifies the fate of adult neural stem cells.

Kuwabara T, Hsieh J, Nakashima K, Taira K, Gage FH.

Cell. 2004 Mar 19;116(6):779-93.

13.

Bmi1 is essential for cerebellar development and is overexpressed in human medulloblastomas.

Leung C, Lingbeek M, Shakhova O, Liu J, Tanger E, Saremaslani P, Van Lohuizen M, Marino S.

Nature. 2004 Mar 18;428(6980):337-41.

PMID:
15029199
15.

Phenylbutyrate and phenylacetate induce differentiation and inhibit proliferation of human medulloblastoma cells.

Li XN, Parikh S, Shu Q, Jung HL, Chow CW, Perlaky L, Leung HC, Su J, Blaney S, Lau CC.

Clin Cancer Res. 2004 Feb 1;10(3):1150-9.

16.

Relaxation of glycine receptor and onconeural gene transcription control in NRSF deficient small cell lung cancer cell lines.

Neumann SB, Seitz R, Gorzella A, Heister A, Doeberitz Mv, Becker CM.

Brain Res Mol Brain Res. 2004 Jan 5;120(2):173-81.

PMID:
14741407
17.

Molecular biology of medulloblastoma therapy.

Pomeroy SL, Sturla LM.

Pediatr Neurosurg. 2003 Dec;39(6):299-304. Review.

PMID:
14734863
18.
19.

Resveratrol promotes differentiation and induces Fas-independent apoptosis of human medulloblastoma cells.

Wang Q, Li H, Wang XW, Wu DC, Chen XY, Liu J.

Neurosci Lett. 2003 Nov 13;351(2):83-6.

PMID:
14583387
20.

A molecular fingerprint for medulloblastoma.

Lee Y, Miller HL, Jensen P, Hernan R, Connelly M, Wetmore C, Zindy F, Roussel MF, Curran T, Gilbertson RJ, McKinnon PJ.

Cancer Res. 2003 Sep 1;63(17):5428-37.

Supplemental Content

Support Center